LONG-TERM KINETICS OF HEPATITIS B SURFACE ANTIGEN (HBSAG) DURING NUCLEOS(T)IDE ANALOGUE THERAPY INDICATE THAT FINITE TREATMENT IS UNLIKELY

被引：0
作者：
Chevaliez, Stephane [1 ]
Hezode, Christophe [1 ]
Bahrami, Stephane [2 ]
Grare, Marion [1 ]
Pawlotsky, Jean-Michel [1 ]
机构：
[1] Henri Mondor Hosp, INSERM, U955, Creteil, France
[2] Univ Paris Est Creteil Val Marne, Paris Hlth Econ & Hlth Serv Res Unit, Creteil, France
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1082A / 1082A
页数：1
相关论文
共 50 条
  • [31] HBSAG LOSS IS ENOUGH TO DISCONTINUE LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN REAL PRACTICE?
    Fasano, M.
    Ciarallo, M.
    Niro, G.
    Fontana, R.
    Cozzolongo, R.
    Maci, A.
    Carraturo, I.
    Miglietta, A.
    Angarano, G.
    Santantonio, T.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E12 - E12
  • [32] CHANGES OF SERUM HBSAG LEVELS IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS UNDER LONG-TERM THERAPY WITH NUCLEOS(T)IDE ANALOGUE(S)
    Papatheodordis, George V.
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Margariti, Ekaterini
    Exarchos, Xenofon
    Kokkonis, George
    Papaioannou, Christos
    Akriviasdis, Evangelos A.
    Manesis, Emanuel K.
    HEPATOLOGY, 2011, 54 : 1054A - 1054A
  • [33] HBSAG LOSS IS ENOUGH TO DISCONTINUE LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN REAL PRACTICE?
    Fasano, M.
    Ciarallo, M.
    Niro, G.
    Fontana, R.
    Cozzolongo, R.
    Maci, A.
    Carraturo, I.
    Miglietta, A.
    Angarano, G.
    Santantonio, T.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S370 - S371
  • [34] NGAL can act as a renal safety biomarker during long-term antiviral therapy with nucleos(t)ide analogue in chronic hepatitis B
    Carey, Ivana
    Verma, Suman
    Audimoolam, Vinod K.
    Oakes, Kath
    Bruce, Matthew J.
    Horner, Mary
    Agarwal, Kosh
    HEPATOLOGY, 2015, 62 : 1210A - 1210A
  • [35] Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Kim, Soon Sun
    Cheong, Jae Youn
    Cho, Sung Won
    GUT AND LIVER, 2011, 5 (03) : 278 - 287
  • [36] Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B
    Ibragimov, E. K.
    Abdurakhmanov, D. T.
    Rozina, T. P.
    Nikulkina, E. N.
    Tanaschuk, E. L.
    Odintsov, A., V
    Panevkina, S., V
    Moiseev, S., V
    TERAPEVTICHESKII ARKHIV, 2019, 91 (02) : 40 - 47
  • [37] Finite nucleos(t)ide analogue therapy in hepatitis Be antigen-negative chronic hepatitis B: From an "option" to an "active recommendation"
    Liaw, Yun-Fan
    Chien, Rong-Nan
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2022, 38 (04) : 295 - 301
  • [38] Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients in Japan
    Suzuki, Fumitaka
    Hosaka, Tetsuya
    Suzuki, Yoshiyuki
    Sezaki, Hitomi
    Akuta, Norio
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Mineta, Rie
    Suzuki, Yukiko
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (02) : 182 - 193
  • [39] RETRACTION: Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment
    Sun, H.
    Liu, Y.
    Zhang, Y.
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [40] Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy
    Velay, A.
    Jeulin, H.
    Eschlimann, M.
    Malve, B.
    Goehringer, F.
    Bensenane, M.
    Frippiat, J-P.
    Abraham, P.
    Ismail, A. M.
    Murray, J. M.
    Combet, C.
    Zoulim, F.
    Bronowicki, J-P.
    Schvoerer, E.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (05) : 387 - 398
12345